About The Study: The results of this study suggest that among children ages 5 to 11, two doses of the Pfizer-BioNTech COVID-19 vaccine provided modest short-term protection against Omicron infection that was higher for those with prior infection; however, vaccine effectiveness waned after approximately three months in all children. A booster dose restored protection against Omicron and was maintained for at least three months. These findings highlight the continued importance of booster vaccination regardless of history of prior COVID-19.
Authors: Farid L. Khan, M.P.H., of Pfizer in Collegeville, Pennsylvania, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2022.46915)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.46915?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121422
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
Journal
JAMA Network Open
